Alagille syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:52OMIM:118450Q44.7
Who is this for?
Show terms as
2FDA treatments5Active trials16Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Alagille Syndrome is treated with 2 medications in our database, including CTEXLI, Livmarli. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Mirum Pharmaceuticals, Mirum. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Alagille Syndrome treatment below.

Also known as:

Clinical phenotype terms— hover any for plain English:

KeratoconusHP:0000563Abnormal pupil morphologyHP:0000615
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

8 events
Mar 2026Pediatric Evaluation and Registry for Liver Cholestasis in Canada

Children's Hospital of Eastern Ontario

TrialNOT YET RECRUITING
Mar 2026Management of Steatorrhea in Children and Young Adults With Alagille Syndrome After Liver Transplantation

Digestive Care, Inc. — PHASE2

TrialNOT YET RECRUITING
Jan 2026A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)

Takeda

TrialRECRUITING
Dec 2025Dental Dyschromia and Quality of Life in Early Prolonged Hyperbilirubinemia

University Hospital, Toulouse

TrialNOT YET RECRUITING
Sep 2025Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome in the European Union (LEAP-EU)

Mirum Pharmaceuticals, Inc. — PHASE4

TrialRECRUITING
Apr 2025A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

Ipsen

TrialRECRUITING
Sep 2023Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

Mirum Pharmaceuticals, Inc.

TrialRECRUITING
Sep 2021Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

Albireo, an Ipsen Company — PHASE3

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

2 available

CTEXLI

chenodiol· Mirum Pharmaceuticals

* Patient Copay Amount: As little as $0 per fill * Maximum Annual Benefit Limit: Not Publicly Available * Core Eligibility Restrictions: For the Savings Program, patients must have commercial insuranc

Livmarli

maralixibat chloride· Mirum

* Patient Copay Amount: $10 or less per fill * Maximum Annual Benefit Limit: Not Publicly Available * Core Eligibility Restrictions: Must be a US resident and enrolled in the Mirum Access Plus (MAP) p

Clinical Trials

5 recruitingView all trials with filters →
Phase 31 trial
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
Phase 3
Actively Recruiting Prior treatment eligible
PI: Ipsen Medical Director (Ipsen) · Sites: San Diego, California; San Francisco, California +18 more
Phase 41 trial
Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome in the European Union (LEAP-EU)
Phase 4
Actively Recruiting
· Sites: Brussels; Ghent +11 more
Other3 trials
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment
Actively Recruiting
PI: Ipsen Medical, Director (Ipsen) · Sites: Los Angeles, California; San Francisco, California +6 more
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
Actively Recruiting
· Sites: Los Angeles, California; Aurora, Colorado +6 more
A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)
Actively Recruiting
PI: Study Director (Takeda) · Sites: Tokyo, Tokyo

Specialists

16 foundView all specialists →
MA
Mohammed D Ayoub
Specialist
2 Alagille syndrome publications
EG
Emmanuel Gonzales
Specialist
2 Alagille syndrome publications
BK
Binita M Kamath
Specialist
5 Alagille syndrome publications
FL
Florence Lacaille
Specialist
4 Alagille syndrome publications
EJ
Emmanuel Jacquemin
Specialist
4 Alagille syndrome publications
KL
Kathleen M Loomes
PHILADELPHIA, PA
Specialist
3 Alagille syndrome publications
SV
Shannon M Vandriel
Specialist
3 Alagille syndrome publications
WH
Winita Hardikar
Specialist
3 Alagille syndrome publications
MS
Michael Stormon
Specialist
3 Alagille syndrome publications
PC
Piotr Czubkowski
Specialist
3 Alagille syndrome publications
HV
Henkjan J Verkade
Specialist
3 Alagille syndrome publications
GI
Giuseppe Indolfi
Specialist
3 Alagille syndrome publications
MG
Melissa A Gilbert
Specialist
2 Alagille syndrome publications
WG
Will Garner
Specialist
3 Alagille syndrome publications
PV
Pamela Vig
Specialist
3 Alagille syndrome publications
NE
Noelle Ebel
PALO ALTO, CA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
⚗️ Trial Site

Boston Children's Hospital

📍 Boston, Massachusetts

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

Travel Grants

1 grants

HealthWell Foundation Financial Assistance Programs

HealthWell Foundation

The HealthWell Foundation provides financial assistance to adults and children to cover out-of-pocket healthcare costs like prescription copayments, deductibles, and premiums. Eligibility is based on financial need relative to the Federal Poverty Level and having health insurance that is insufficient to cover treatment costs.

Apply ↗

Community

Open Alagille syndromeForum →

No community posts yet. Be the first to share your experience with Alagille syndrome.

Start the conversation →

Latest news about Alagille syndrome

1 articles
NewsHEPATOL INTMar 21, 2026
AGEX: a comprehensive database of clinically relevant genetic variants associated with Alagille syndrome across diverse populations
Published in Hepatol Int. Sharma P et al.
See all news about Alagille syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Alagille syndrome

What is Alagille syndrome?

Alagille Syndrome is treated with 2 medications in our database, including CTEXLI, Livmarli. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Mirum Pharmaceuticals, Mirum. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Alagille Syndrome treatment below.

How is Alagille syndrome inherited?

Alagille syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Alagille syndrome typically begin?

Typical onset of Alagille syndrome is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Alagille syndrome?

Yes — 5 recruiting clinical trials are currently listed for Alagille syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Alagille syndrome?

16 specialists and care centers treating Alagille syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Alagille syndrome?

2 FDA-approved treatments and 1 patient support program are currently tracked on UniteRare for Alagille syndrome. See the treatments and support programs sections for copay assistance, eligibility, and contact details.